Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001123292-25-000613·Arcus Biosciences, Inc.
Schedule 13D ownership disclosure
Arcus Biosciences Inc
Common Stock, par value $0.0001 · CUSIP: 03969F109
Event date: 2025-11-03
- Filing-level shares
- 31,424,760
- Percent of class
- 25.6%
- GILEAD SCIENCES, INC.Reported CIK 0000882095
Shares: 31,424,760 · Class: 25.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001123292-25-000613
- Form type
- SCHEDULE 13D/A
- Filer
- Arcus Biosciences, Inc.
- CIK
- CIK 1724521
- Filed
- Nov 05, 2025
- Reporting period
- Nov 03, 2025
- Description
- Schedule 13D beneficial ownership